|
|
Volumn 343, Issue 22, 2000, Pages 1640-1641
|
|
Biologic therapy for rheumatoid arthritis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ETANERCEPT;
GLUCOCORTICOID;
INFLIXIMAB;
METHOTREXATE;
DEMYELINATING DISEASE;
DRUG COST;
DRUG EFFECT;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
DRUG INDICATION;
EDITORIAL;
HUMAN;
MEDICARE;
PRIORITY JOURNAL;
REIMBURSEMENT;
RHEUMATOID ARTHRITIS;
UPPER RESPIRATORY TRACT INFECTION;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
HUMANS;
IMMUNOGLOBULIN G;
RECEPTORS, TUMOR NECROSIS FACTOR;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 0034735839
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200011303432210 Document Type: Editorial |
|
Times cited : (49)
|
|
References (9)
|
